• Home
  • Biopharma AI
  • Can OpenLoop’s Acquisition of Hey Revia Redefine How AI Automates Telehealth Communication for Thousands of Providers?

Can OpenLoop’s Acquisition of Hey Revia Redefine How AI Automates Telehealth Communication for Thousands of Providers?

Key Highlights

  • OpenLoop has acquired Hey Revia, an AI-powered voice and patient communication platform, folding its automated tools directly into Launchpad, OpenLoop’s self-service platform that lets organizations build and deploy branded telehealth services.
  • The deal deepens OpenLoop’s push into workflow automation, with Hey Revia’s technology built to handle insurance verification, prior authorizations, pharmacy coordination, and multi-channel patient communication across phone, email, text, and fax.
  • The acquisition arrives alongside the appointment of Sowmya Subramanian (ex-Warner Bros. Discovery, Oracle, Quizlet, Google) as OpenLoop’s first Chief Technology and Product Officer, and follows a string of strategic moves including the Season Health acquisition and a new remote patient monitoring partnership with Tenovi and RxHealing.

A Landmark Acquisition Strengthening OpenLoop’s Virtual Care Ecosystem

OpenLoop, the Iowa-based telehealth infrastructure company known for supporting digital health organizations with regulatory, legal, staffing, revenue cycle, and operational services, has announced the acquisition of Hey Revia, a company purpose-built to automate the administrative backbone of patient communication. The move signals OpenLoop’s continued ambition to become the connective infrastructure layer underpinning modern virtual care, one where AI does not just support clinicians but actively removes friction from the entire patient journey.

Inside the Deal: What Hey Revia Brings to Launchpad

Hey Revia’s AI-enabled voice and communication tools are designed to automate some of healthcare’s most persistent operational bottlenecks, insurance verification, prior authorizations, and pharmacy coordination, while managing patient communications across phone, email, text messaging, and fax. By integrating these capabilities into Launchpad, OpenLoop’s self-service platform for building branded telehealth services, healthcare organizations gain a faster, more automated path to standing up patient-facing communication infrastructure without building it from scratch.

Talent and Leadership: Building the Team Behind the Technology

As part of the transaction, Hey Revia cofounders Shaun Wei and David Zhu are joining OpenLoop, with Wei stepping in as Executive Vice President of Engineering and Zhu as Senior Director of Engineering. The acquisition also coincides with the appointment of Sowmya Subramanian as OpenLoop’s first Chief Technology and Product Officer. Reflecting on the opportunity, Subramanian said OpenLoop has built “an end-to-end infrastructure layer for healthcare, with real clinical depth and operational scale,” and that putting AI-powered systems to work where they measurably improve care quality and access is exactly the challenge she wants to solve.

Part of a Bigger Pattern: OpenLoop’s Expanding AI-Driven Platform

The Hey Revia acquisition is the latest in a series of strategic moves for OpenLoop. In April, the company acquired food-as-medicine platform Season Health, bringing nutrition and recipe-planning capabilities into its virtual care programs. More recently, OpenLoop partnered with Tenovi and RxHealing to launch a nationwide remote patient monitoring program, helping independent pharmacies support patients with chronic conditions between provider visits through clinical oversight, compliance, and billing infrastructure. Together, these moves point to a company steadily assembling an AI-enabled, end-to-end infrastructure stack for the next generation of virtual care delivery.

Releated Posts

Can Attovia Therapeutics’ Nasdaq IPO Signal a Broader Biotech Funding Revival Backed by Goldman Sachs and Deep Track Capital?

Key Highlights A Landmark Filing Reflecting Renewed Confidence in Biopharma Innovation Attovia Therapeutics’ decision to file for a…

ByByAnuja Singh Jul 20, 2026

Is the $2.5 Billion Insilico Medicine-Bora Pharmaceuticals Alliance the Blueprint for AI-Native Pharma’s Next Decade?

Key Highlights A Landmark Alliance Bridging AI Discovery and Global Manufacturing In a move set to reshape the…

ByByAnuja Singh Jul 20, 2026

Can Aspira Women’s Health and Cleveland Clinic’s New AI Alliance Rewrite the Rules for Women’s Diagnostics Across Ovarian Cancer and Beyond?

Key Highlights A Strategic Alliance Built for Scale Aspira Women’s Health and Cleveland Clinic have entered a comprehensive…

ByByAnuja Singh Jul 16, 2026

Will Big Pharma’s Billion-Dollar AI Investments Reshape the US$2 Trillion Pharmaceutical Industry Faster Than the Next Blockbuster Drug?

Key Highlights The AI Investment Race Has Officially Begun Artificial intelligence has rapidly evolved from an experimental technology…

ByByAnuja Singh Jul 14, 2026

Leave a Reply

Your email address will not be published. Required fields are marked *

Scroll to Top